期刊文献+

无导线起搏临床应用进展 被引量:5

Progress in clinical application of leadless pacemaker
原文传递
导出
摘要 永久起搏器是症状性缓慢性心律失常的基本治疗方法,传统心脏起搏器植入存在导线、囊袋相关及术后并发症等风险。无导线心脏起搏器的出现解决了上述问题。本文将围绕无导线起搏器的特性、多种起搏方式的交叉应用、无导线相关并发症、最新临床应用进展做一系统阐述。
作者 薄雅坤 周贤惠 芦颜美 汤宝鹏 Bo Yakun;Zhou Xianhui;Lu Yanmei;Tang Baopeng(Department of Pacing and Electrophysiology,Department of Cardiac Electrophysiology and Remodeling,The First Affiliated Hospital of Xinjiang Medical University,Urumqi 830054,China)
出处 《中华心律失常学杂志》 2021年第1期61-64,共4页 Chinese Journal of Cardiac Arrhythmias
基金 国家重点研发计划精准研究(2016YFC0900905)。
  • 相关文献

参考文献2

二级参考文献33

  • 1Mond HG, Proclemer A. The 11 th world and implantablc World Society of survey of cardiac pacing calendar year 2009: a Arrhythmia' s project[J]. Pacing Clin Electro- physio1,2011,34 : 1013-1027.
  • 2Yokoshiki H, Mitsuyama H, Watanabe M, et al. Anticoagulation management in the perioperative phase of implantable cardioverter defibrillator implantation[ J]. Circ J,2013,77 : 2003-2008.
  • 3Ohlow MA, Laner B, Brunelli M, et al. Incidence and predictors of perieardial effusion after permanent heart rhythm device implan- tation: Prospective evaluation of 968 consecutive patients[ J ]. Circ J,2013,77 : 975-981.
  • 4Ozcan KS, Osmonov D,Ylldmm E, et al. Hematoma complicating permanent pacemaker implantation: The role of periprocedural anti-platelet or anticoagulant therapy[ J]. ] Cardiol, 2013,62: 127-130.
  • 5Douketis JD,Johnson JA,Turpie AG. Low-moleeular-weigbt hepa- tin as bridging anticoagulation during interruption of warfarin : as- sessment of a standardized periprocedural anticoagulation regimen [J]. Arch Intern Med,2004,164: 1319-1326.
  • 6Wiegand UK, LeJeune D, Boguschewski F, et al. Pocket hemato- ma after pacemaker or implantable cardioverter defibrillator surger- y : influence of patient morbidity, operation strategy, and perioper- ative antiplatelet/antieoagulation therapy [ J ]. Chest, 2004,126 : 1177-1186.
  • 7Aggarwal RK, Connelly DT, Ray SG,et al. Early complications of permanent pacemaker implantation: no difference between dual and single chamber systems[ J]. Br Heart J, 1995,73:571-575.
  • 8Jamula E, Dotaketis JD, Sehulman S. Perioparative anticoagula- tion in patients having implantation of a cardiac pacemaker or de- fibrillator: a systematic review and practical management guide [ J ]. J Thmmb Hacmost,2008,6 : 1615-1621.
  • 9Phibbs B, Marriott HI. Complications of permanent transvenous pacing[J]. N Engl J Med, 1985,312:1428-1432.
  • 10Douketis JD, Berger PB, Dunn AS,et al. The perioperative man- agement of antithrombotic therapy: American College of Chest Physicians evidence-based clinical practice guidelines (8th edi- tion) [ J]. Chest,2008,133:299S-339S.

共引文献15

同被引文献11

引证文献5

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部